STAT

A congresswoman from Silicon Valley wants to lead on health care. New attack ads say she’s ‘in the pocket of Big Pharma’

A group that's buying ads to try to elevate the issue of high drug prices in the midterm elections has identified its latest target: @RepAnnaEshoo, a Democratic congresswoman from Silicon…
Rep. Anna Eshoo (D-Calif.)

SAN FRANCISCO — A group that’s buying ads to try to elevate the issue of high drug prices in the midterm elections has identified its latest target: a Democratic congresswoman from Silicon Valley who wants to lead on health care issues.

Patients For Affordable Drugs Action will spend $500,000 on ads attacking Rep. Anna Eshoo for her legislative record and for accepting campaign contributions from the drug industry, the group announced Friday. Eshoo is expected to be re-elected easily in November.

The super PAC is led by David Mitchell, a cancer in shaping the debate around drug pricing.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks